Robert Piskol
Impact in
- Molecular Biology top 2%
- RNA regulation and disease
- RNA modifications and cancer
- Genomics and Phylogenetic Studies
- Wnt/β-catenin signaling in development and cancer
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA regulation and disease 9
- RNA and protein synthesis mechanisms 5
- Wnt/β-catenin signaling in development and cancer 4
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- Cancer Cells and Metastasis 3
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Jin Billy Li (11 shared papers)Gokul Ramaswami (6 shared papers)Zora D. Modrusan (10 shared papers)Alistair Morgan Chalk (5 shared papers)Brian Liddicoat (5 shared papers)Peter H. Seeburg (5 shared papers)Carl R. Walkley (5 shared papers)Jochen C. Hartner (5 shared papers)
- Journals
- Nature (4 papers)Molecular Cancer Therapeutics (2 papers)Experimental Hematology (2 papers)Nature Biotechnology (2 papers)Molecular Biology and Evolution (2 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Robert Piskol
41 papers receiving 4.2k citations
Robert Piskol's Hit Papers
Peers
Comparison fields: 5 of 98
- Molecular Biology 2.5k
- Oncology 787
- Immunology 583
- Cancer Research 212
- Genetics 241
Countries citing papers authored by Robert Piskol
This map shows the geographic impact of Robert Piskol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Piskol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Piskol more than expected).
Fields of papers citing papers by Robert Piskol
This network shows the impact of papers produced by Robert Piskol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Piskol. The network helps show where Robert Piskol may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Piskol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself Hit paper breakdown → | 2015 | 745 |
| 2 | A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer Hit paper breakdown → | 2017 | 636 |
| 3 | Dynamic landscape and regulation of RNA editing in mammals Hit paper breakdown → | 2017 | 473 |
| 4 | 2020 | 337 | |
| 5 | 2012 | 310 | |
| 6 | 2013 | 296 | |
| 7 | 2013 | 275 | |
| 8 | 2019 | 152 | |
| 9 | 2018 | 112 | |
| 10 | 2020 | 111 | |
| 11 | 2021 | 99 | |
| 12 | 2018 | 73 | |
| 13 | 2017 | 63 | |
| 14 | 2016 | 60 | |
| 15 | 2013 | 56 | |
| 16 | 2019 | 48 | |
| 17 | 2020 | 48 | |
| 18 | 2014 | 45 | |
| 19 | 2021 | 33 | |
| 20 | 2023 | 30 |
About Robert Piskol
Robert Piskol is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 43 papers that have together received 4.2k indexed citations. Recurring topics across this work include RNA regulation and disease (9 papers), RNA and protein synthesis mechanisms (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers), Evolution and Genetic Dynamics (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Molecular Biology (2.5k citations), Oncology (787 citations), Immunology (583 citations), Cancer Research (212 citations) and Genetics (241 citations). Robert Piskol has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Jin Billy Li, Gokul Ramaswami, Zora D. Modrusan, Alistair Morgan Chalk, Brian Liddicoat, Peter H. Seeburg, Carl R. Walkley, Jochen C. Hartner, Frédéric J. de Sauvage and Felipe de Sousa e Melo. Their work appears in journals such as Nature, Molecular Cancer Therapeutics, Experimental Hematology, Nature Biotechnology and Molecular Biology and Evolution.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.